Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I study of ZD1839 plus temozolomide in patients with malignant glioma. A North American Brain Tumor Consortium study

Phase I study of ZD1839 plus temozolomide in patients with malignant glioma. A North American Brain Tumor Consortium study. Proc ASCO. 2004.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.